Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines

HM Coley; CF Shotton; H Thomas

Back

Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines

Journal article

Peer reviewed

Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines

HM Coley, CF Shotton and H Thomas

ANTICANCER RESEARCH, Vol.27(1A), pp.273-278

01/01/2007

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

uterine cancer

seliciclib

paclitaxel

combination therapy

apoptosis

APOPTOSIS

INHIBITION

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244545200035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

27 Record Views

Details

Title: Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines
Creators: HM Coley
CF Shotton
H Thomas
Publication Details: ANTICANCER RESEARCH, Vol.27(1A), pp.273-278
Publisher: INT INST ANTICANCER RESEARCH
Date published: 01/01/2007
Date submitted: 17/05/2017
Identifiers: 99512173202346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines

Abstract

Files and links (1)

Metrics

Details

Usage Policy